PARIS (dpa-AFX) - French drug major Sanofi (SNYNF, SNY) announced Tuesday a
collaboration with Formation Bio and AI research and deployment company OpenAI
to build AI-powered software to accelerate drug development and bring new
medicines to patients more efficiently.

Under the deal, the companies would bring together data, software and tuned
models to develop custom, purpose-built solutions across the drug development
lifecycle.

Sanofi said it will leverage the partnership to provide access to proprietary
data to develop AI models as it continues on its path to becoming the first
biopharma company powered by AI at scale.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX